ZNF154 and esophageal squamous cell carcinoma: developed a targeted demethylation system utilising CRISPR/dCas9 technology, which confirmed that dCas9‐TET1CD induced demethylation of the ZNF154 promoter could activate ZNF154 expression, thereby inhibiting the proliferation and migration of ESCC cells.19